Inscripciones abiertas al 1er Máster de Contratación Pública Sanitaria y Compliance

Este nuevo máster, que se inicia en enero 2016 y está coordinado por la consultora especialista en contratación pública sanitaria Tesera de Hospitalidad y la Sociedad Española de Directivos de la Salud (SEDISA), aporta un valor diferencial a los profesionales que centran su actividad profesional en este campo y necesitan una puesta al día con una visión de 360° eminentemente práctica.

hitt at the Health Economic Summer School – Heidelberg University

What are the conceptual foundations and limitations of the current health economic evaluation paradigm? What are the implications of its actual use in the context of health Technology Assessments (HTAs) and decision-making on market access, pricing and reimbursement of medical technologies? hitt will contribute to answer these and more questions in this high–level program offered by the[…]

Rare Diseases – Innovation in Funding & Reimbursement, and Insight into Societal Preferences.

Despite the continuing progress made in the R&D of orphan drugs to diagnose and treat rare diseases, the issue of rarity continues to ignite controversies and debates on the scientific, economic, and political grounds. While great efforts are being made both nationally and internationally to collaborate and advance in our knowledge and policies regarding rare diseases, little – albeit growing – attention is paid to societies’ values and preferences when it comes to the trade-offs to be made when allocating public resources.